| Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has excipient |
Excipient not declared |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has NHS dm+d (dictionary of medicines and devices) controlled drug category |
Controlled drug category No Controlled Drug Status |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator |
NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
VMP non-availability indicator |
Not available |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Is a |
Eptacog alfa (activated) 2mg (100,000unit) powder and solvent for solution for injection vials |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has active ingredient |
Eptacog alfa |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has manufactured dose form |
Powder for conventional release solution for injection |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
VMP prescribing status (attribute) |
VMP valid as a prescribable product |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
VMP non-availability indicator |
Available |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has excipient |
Polysorbate |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Is a |
NovoSeven |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has specific active ingredient |
Eptacog alfa |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has dispensed dose form |
Powder and solvent for solution for injection |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Is a |
Actual medicinal product |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| NovoSeven 100,000unit powder and solvent for solution for injection vials (Novo Nordisk Ltd) |
Has manufactured dose form |
Powder and solvent for solution for injection |
true |
Inferred relationship |
Existential restriction modifier |
|
|
FHIR